Skip to content

Biovie Inc.

BIVIW· Nasdaqxbrl foundCIK 1580149

Pharmaceutical preparations552 peers

Last sale
Nov 6, 2026
Market cap
—
no share count on file
Filings
512
$0.00
Q1 2016
—
-$5.61M
Q1 2027N/M FY26 yoy
-$5.65M
Q1 2027N/M FY26 yoy
—
—
—
-$0.68
Q1 2027N/M FY26 yoy
$7.73M
Q1 2027−48.8% FY26 yoy

Price

$0.2659+2.27%+$0.0059since Nov 19, 2025
Nov 6, 2026 · IEX last sale
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$13.96MFY 2026
$33.30M0FY 2015FY 2021FY 2026
PeriodEndedValueKindSource trail
FY 20262026-06-30$13,962,360reported
FY 20252025-06-30$9,266,734reported
FY 20242024-06-30$23,100,394reported
FY 20232023-06-30$33,299,503reported
FY 20222022-06-30$17,258,341reported
FY 20212021-06-30$2,544,648 revisedreported
FY 20202020-06-30$1,150,581reported
FY 20182019-06-30$1,008,100reported
FY 20172018-06-30$370,852reported
FY 20162016-06-30$37,901reported
FY 20152015-06-30$4,196reported

Pharmaceutical preparations

Biovie Inc. is the 408th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR